| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6167508 | Urology | 2013 | 7 Pages |
Abstract
The results of our study have shown that repeated onabotulinumtoxinA treatments provide sustained reductions in UI episodes and increases in the volume/void and quality of life in patients with neurogenic detrusor overactivity and UI who were inadequately managed by anticholinergics, with no new safety signals.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael Kennelly, Roger Dmochowski, Karen Ethans, Gilles Karsenty, Heiner Schulte-Baukloh, Brenda Jenkins, Catherine Thompson, Daniel Li, Cornelia Haag-Molkenteller,